GlassScriptPhysician profile
Eric Michael Noll
NPI 1912432691
$3,145.21
in general payments reported to CMS, 2019-2025
26 companies · $394 in 2025
The $394 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,121 · 2022: $324 · 2023: $726 · 2024: $581 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,700.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $562.99 | 2021-2025 | Lifevest |
| Amgen INC. | $374.48 | 2022-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $372.32 | 2021-2025 | Farxiga, Andexxa |
| Boston Scientific Corporation | $170.97 | 2021-2024 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Amarin Pharma, INC. | $155.86 | 2021 | |
| Novartis Pharmaceuticals Corporation | $149.49 | 2021-2024 | |
| Novo Nordisk INC | $139.84 | 2021-2025 | Wegovy |
| Sanofi-Aventis U.S. LLC | $126.94 | 2022-2023 | |
| Abbott Laboratories | $118.97 | 2021 | |
| Esperion Therapeutics, INC. | $105.82 | 2021-2023 | Nexletol |
| Merck Sharp & Dohme LLC | $103.95 | 2021-2023 | Verquvo |
| Janssen Pharmaceuticals, INC | $103.27 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.20 | 2021-2025 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $83.15 | 2021-2024 | Uptravi, Opsumit |
| Astellas Pharma US INC | $82.96 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $78.51 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Impulse Dynamics (USA) INC. | $78.12 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $40.34 | 2023 | Evkeeza |
| Pfizer INC. | $39.79 | 2024 | |
| Acacia Pharma INC | $37.25 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $32.68 | 2021-2024 | Eliquis |
| Cmp Pharma, INC. | $20.83 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $20.66 | 2023 | Inpefa |
| Lundbeck LLC | $20.06 | 2021 | |
| Medtronic, INC. | $17.42 | 2023 | Endurant Iis |
| Kiniksa Pharmaceuticals, LTD. | $17.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Noll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.